RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Hypertension Diagnostics - Stock

Hypertension Diagnostics Stocks 2024

Hypertension Diagnostics Stocks

52.39 M

Ticker

HDII

ISIN

US44914V1044

WKN

657841

In 2024, Hypertension Diagnostics had 52.39 M outstanding stocks, a 0% change from the 52.39 M stocks in the previous year.

The Hypertension Diagnostics Stocks history

YEARNUMBER OF STOCKS (undefined USD)
201852.39
201752.39
201652.39
201246.82
201142.65
201041.28
200940.72
200839.69
200739.79
200635.22
200528.51
200421.75
20038.38
20025.96
20015.37
20005.13
19994.97
19982.22
19971.96
19961.25

Hypertension Diagnostics shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Hypertension Diagnostics earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Hypertension Diagnostics's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Hypertension Diagnostics’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Hypertension Diagnostics's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Hypertension Diagnostics Aktienanalyse

What does Hypertension Diagnostics do?

Hypertension Diagnostics Inc. is a biotechnology company specializing in the development and production of medical devices for the diagnosis of arterial hypertension. The company was founded in 1999 by a team of experienced engineers and scientists with the goal of providing the healthcare sector with new effective solutions for the widespread problem of high blood pressure. Hypertension Diagnostics' business model is based on the development and marketing of medical devices for blood pressure measurement, specifically designed for clinical and ambulatory use in medical practices, clinics, or at home. The company's technology aims to provide better and more reliable options for early detection and treatment of hypertension, ultimately contributing to a reduction in associated risks such as cardiovascular diseases, kidney failure, and strokes. Hypertension Diagnostics offers various divisions in their business. These include product development, sales and marketing team, as well as customer support team. The company also operates a research and development department focused on clinical studies and continuous improvement of existing products. Hypertension Diagnostics' products include blood pressure measurement devices with various features, such as portable devices for home use, certified blood pressure monitors for ambulatory and clinical diagnostics, as well as blood pressure monitors for operation under adverse conditions. This also includes wireless monitoring systems that allow doctors to monitor the blood pressure behavior of patients over an extended period without the patient having to stay in the hospital. The company has also developed a range of software applications that can access and analyze patient data. The goal of Hypertension Diagnostics is to provide the healthcare sector with innovative and high-quality blood pressure measurement devices that enable better early detection and treatment of hypertension for physicians, clinics, and patients. The company is committed to continuously developing and improving its technology to better meet the needs of its customers and patients. Overall, Hypertension Diagnostics is a company focused on improving healthcare through innovative medical devices for the diagnosis of high blood pressure. The company has a strong track record in the development and marketing of blood pressure measurement devices and has earned an excellent reputation in the industry. Thanks to its strong R&D team and commitment to product quality, Hypertension Diagnostics is expected to continue playing a key role in providing advanced medical solutions to reduce the rate of hypertension-related diseases in the future. Hypertension Diagnostics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Hypertension Diagnostics's Shares Outstanding

Hypertension Diagnostics's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Hypertension Diagnostics’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Hypertension Diagnostics’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Hypertension Diagnostics’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Hypertension Diagnostics Stock

How many stocks are there of Hypertension Diagnostics?

The current number of stocks of Hypertension Diagnostics is 52.39 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Hypertension Diagnostics are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Hypertension Diagnostics evolved in recent years?

The number of shares of Hypertension Diagnostics has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Hypertension Diagnostics as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Hypertension Diagnostics?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Hypertension Diagnostics pay?

Over the past 12 months, Hypertension Diagnostics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Hypertension Diagnostics is expected to pay a dividend of 0 USD.

What is the dividend yield of Hypertension Diagnostics?

The current dividend yield of Hypertension Diagnostics is .

When does Hypertension Diagnostics pay dividends?

Hypertension Diagnostics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Hypertension Diagnostics?

Hypertension Diagnostics paid dividends every year for the past 0 years.

What is the dividend of Hypertension Diagnostics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Hypertension Diagnostics located?

Hypertension Diagnostics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hypertension Diagnostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hypertension Diagnostics from 6/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/16/2024.

When did Hypertension Diagnostics pay the last dividend?

The last dividend was paid out on 6/16/2024.

What was the dividend of Hypertension Diagnostics in the year 2023?

In the year 2023, Hypertension Diagnostics distributed 0 USD as dividends.

In which currency does Hypertension Diagnostics pay out the dividend?

The dividends of Hypertension Diagnostics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Hypertension Diagnostics

Our stock analysis for Hypertension Diagnostics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hypertension Diagnostics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.